Samumed launches phase III clinical program for lorecivivint in knee osteoarthritis May 3, 2019 No Comments
Discovery of novel selective hematopoietic prostaglandin D synthase inhibitors April 29, 2019 No Comments
Phase III COAST-X study of Taltz in nonradiographic axial spondyloarthritis meets key endpoints April 23, 2019 No Comments
Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical patent JAK inhibitors April 17, 2019 No Comments
RSS